Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients
Most ovarian masses in children and adolescents are benign.
Established practice
Unnecessary oophorectomy can have lifelong negative effects on health.
Established practice
The study included patients aged 6 to 21 years undergoing surgery for an ovarian mass across 11 children's hospitals in the United States between August 2018 and January 2021.
Cites published research
Benign disease was present in 93 (96.9%) patients in the preintervention cohort and 298 (93.7%) in the intervention cohort.
Cites published research
The percentage of unnecessary oophorectomies decreased from 16.1% preintervention to 8.4% during the intervention, an absolute reduction of 7.7%.
Cites published research
The algorithm achieved a sensitivity of 91.6% for identifying benign lesions in the intervention cohort.
Cites published research
The algorithm achieved a specificity of 90.0% for identifying benign lesions in the intervention cohort.
Cites published research
The algorithm achieved a positive predictive value of 99.3% for identifying benign lesions in the intervention cohort.
Cites published research
The algorithm achieved a negative predictive value of 41.9% for identifying benign lesions in the intervention cohort.
Cites published research
The proportion of misclassification in the intervention phase, defined as malignant disease treated with ovary-sparing surgery, was 0.7%.
Cites published research
Algorithm adherence during the intervention phase was 95.0%, with fidelity of 81.8%.
Cites published research
Use of a preoperative risk stratification algorithm to identify lesions with a high likelihood of benign pathology can reduce unnecessary oophorectomies.
Use of Radiographic Features for Risk Stratification of Ovarian Masses in Children and Adolescents
Radiographic features suspicious for malignancy should prompt further evaluation including a multidisciplinary discussion for consideration of ovarian sparing surgery versus oophorectomy.
The presence of a complex mass, solid component, or tumor size greater than 8 cm was reported in 26 of 27 malignant tumors.
Cites published research
All 26 malignant tumors were identified when one of these radiographic features (complex mass, solid component, or tumor size greater than 8 cm) was present, conferring a negative predictive value of 100% with 65.1% accuracy.
Cites published research
The combination of radiographic evidence of metastatic disease and increased β-human gonadotropin, cancer antigen 125, or inhibin A identified all malignant tumors.
Cites published research
Atypical Presentation of Granulosa Cell Tumor in an Adolescent: A Case Report.
Granulosa cell tumors frequently present with elevated levels of estrogen and inhibin.
Established practice
Most diagnoses of granulosa cell tumors in the pediatric and adolescent population are juvenile-type; adult-type granulosa cell tumors in this population are rare.
Established practice
A 14-year-old female presented with a large adnexal mass and clinical hyperandrogenism with elevated levels of free and total testosterone.
Cites published research
Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.
Small cell carcinoma of the ovary hypercalcemic type (SCCOHT) is a rare and aggressive disease.
Established practice
SCCOHT is classically linked to mutations in SMARCA4.
Established practice
A case of SCCOHT has been identified in a patient with both SMARCA4 and BRCA2 germline mutations.
Cites published research
Treatment approaches for SCCOHT include adjuvant systemic chemotherapy, interval hyperthermic intraperitoneal chemotherapy, and high-dose chemotherapy.
Cites published research
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
Small cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is an extremely rare, aggressive cancer affecting children and young women.
Established practice
Germline and somatic inactivating mutations in the SWI/SNF chromatin-remodeling gene SMARCA4 were identified in 75% (9/12) of SCCOHT cases.
Cites published research
SMARCA4 protein loss was found in 82% (14/17) of SCCOHT tumors.
Cites published research
SMARCA4 protein loss was found in only 0.4% (2/485) of other primary ovarian tumors.
Cites published research
SMARCA4 is implicated in SCCOHT oncogenesis.
Cites published research
Successful treatment of preadolescents with small cell carcinoma of the ovary hypercalcemic type
Small cell carcinoma of the ovary hypercalcemic type is a rare tumor with a peak incidence in young adulthood that historically has carried a poor prognosis.
Established practice
Two advanced stage cases of SCCOHT in preadolescents were successfully treated with a combination of cisplatin-based chemotherapy and surgical resection.
Cites published research